By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Wealth Beat NewsWealth Beat News
  • Home
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Notification Show More
Aa
Wealth Beat NewsWealth Beat News
Aa
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Follow US
Wealth Beat News > Investing > Hold Netflix And Sell Short Boston Scientific
Investing

Hold Netflix And Sell Short Boston Scientific

News
Last updated: 2023/08/07 at 10:26 AM
By News
Share
2 Min Read
SHARE

Over the near term, the indices are likely to move higher into the 14th. We have moved into the seasonally weaker August-September period. A correction is due before a strong Q4 begins. Cycles project a late-month high. The annual cycle and the 1.88-year cycle both top at that time. The peak in the latter cycle tilts the scale in favor of the September bears.

Netflix
NFLX
is highly ranked in second place in one Cycles Research screen. In August, the shares have risen 55% of the time over the last 21 years and have risen 67% of the time in both the months of September and October. Price appreciation in September has been scant, but has been second strongest in October. The monthly cycle rises into mid-September. This stock is unlikely to give back much of its price gains in the autumn. The stock can be held through any autumn turbulence.

Netflix Daily, Weekly, Monthly

Boston Scientific is on the opposite side of the ledger. It is lowly ranked in the screens. In the graph below, we can see the divergences between price versus relative strength and momentum. Monthly, the stock price is at its most overbought since 2007. There is much room to fall. Seasonally, we can see that the stock is entering its weakest season while the monthly price cycle is falling.

Read the full article here

News August 7, 2023 August 7, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Excelerate Energy: Nearby Best Energy-Source Cap-Gain Prospect (NYSE:EE)

The primary focus of this article is Excelerate Energy, Inc. (NYSE:EE). Investment…

Penske Is Steady, But The Road Ahead May Be Bumpy (NYSE:PAG)

Investing Thesis On Wednesday, Penske Automotive Group (NYSE:PAG) released a superficially encouraging…

Top Financial – No, Stop It, This Is Silly (NASDAQ:TOP)

TOP Financial Moves, yes, but why? TOP Financial (NASDAQ:TOP) was quite the…

You Might Also Like

Investing

Gold ETFs Endure Outflows In November But Withdrawals Slow

By News
Investing

Paccar, AWK, Quanta Services, Mastercard, Deere

By News
Investing

Buyback Bonanza Lifts Stocks

By News
Investing

Why Our Top Natural Gas Stock Will Soar In 2024

By News
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Contact US
More Info
  • Newsletter
  • Finance
  • Investing
  • Small Business
  • Dept Management

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions

Join Community

2025 © wealthbeatnews.com. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc.

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Lost your password?